Sae antibodies

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The SAE antibody (SAE stands for the acronym: small ubiquitin-like modifier activating enzyme) is found in about 5-8% of adult dermatomyositis. Typically, patients initially present with skin symptoms only and develop myositis later in the course of the disease. The SAE antibody is associated with a low incidence of malignancies or interstitial lung disease.

General informationThis section has been translated automatically.

The SAE antibody (SAE stands for the acronym: small ubiquitin-like modifier activating enzyme) is found in about 5-8% of adult dermatomyositis. Typically, patients initially present with skin symptoms only and develop myositis later in the course of the disease. The SAE antibody is associated with a low incidence of malignancies or interstitial lung disease.

LiteratureThis section has been translated automatically.

  1. Volc-Place B (2015) Dermatomyositis update. Dermatologist 66:604-610

Authors

Last updated on: 29.10.2020